Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In all kingdoms of life, the enzyme uridine diphosphate-glucose pyrophosphorylase (UGP) occupies a central role in metabolism, as its reaction product uridine diphosphate-glucose (UDP-Glc) is involved in various crucial cellular processes. Pathogens, including fungi, parasites, and bacteria, depend on UGP for the synthesis of virulence factors; in particular, various bacterial species utilize UDP-Glc and its derivatives for the synthesis of lipopolysaccharides, capsular polysaccharides, and biofilm exopolysaccharides. UGPs have, therefore, gained attention as anti-bacterial drug target candidates, prompting us to study their structure-function relationships to provide a basis for the rational development of specific inhibitors. UGP function is tied to its oligomeric state, and the majority of bacterial homologs have been described as tetramers encoded by the gene. Uniquely, enterobacterial species harbor a second gene, , encoding a protein with high homology to UGP, whose function is somewhat controversial. Here, we show that the gene of the opportunistic pathogen encodes a dimeric protein that has lost UGP activity, likely due to a combination of active site mutations and an inability to tetramerize, whereas the functional UGP, encoded by , is an active tetramer. Our AlphaFold-assisted structure-function relationship studies underline that tetramerization is essential for bacterial UGP function and is facilitated by a common mechanism utilizing conserved key residues. Targeting the respective molecular interfaces, which are absent in human UGP, could provide a means of selectively inhibiting the bacterial virulence factor UGP and potentially rendering pathogenic species avirulent.IMPORTANCEThe enzyme uridine diphosphate-glucose pyrophosphorylase (UGP) is important for the virulence of bacterial pathogens and, therefore, a potential drug target. In this study, we identify the gene encoding the functional UGP in , a bacterium notoriously causing severe antibiotic-resistant infections in humans, and reveal structural and functional features that may aid in the development of new antibiotics.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796359PMC
http://dx.doi.org/10.1128/mbio.02071-24DOI Listing

Publication Analysis

Top Keywords

uridine diphosphate-glucose
12
ugp function
12
ugp
11
enzyme uridine
8
diphosphate-glucose pyrophosphorylase
8
pyrophosphorylase ugp
8
drug target
8
gene encoding
8
functional ugp
8
bacterial
5

Similar Publications

Artificial starch production from bioreactors is very promising in terms of amylose's broad applications as well as the possibility of addressing food shortage. We previously built an in vitro cellulose-to-starch pathway, synthesizing amylose from non-food cellulose. A challenge of this pathway lies in its low amylose yield due to the fact that only cellobiose in cellulose hydrolysate can be converted into amylose while cellodextrins with a degree of polymerization (DP) ≥ 3 cannot be utilized.

View Article and Find Full Text PDF

Epimerases and dehydratases are widely studied members of the extended short-chain dehydrogenase/reductase (SDR) enzyme superfamily and are important in nucleotide sugar conversion and diversification, for example, the interconversion of uridine diphosphate (UDP)-linked glucose and galactose. Methanothermobacter thermautotrophicus contains a cluster of genes, the annotations of which indicate involvement in glycan biosynthesis such as that of cell walls or capsular polysaccharides. In particular, genes encoding UDP-glucose 4-epimerase related protein (Mth375), UDP-glucose 4-epimerase homologue (Mth380) and dTDP-glucose 4,6-dehydratase related protein (Mth373) may be involved in the biosynthesis of an unusual aminosugar in pseudomurein.

View Article and Find Full Text PDF

Congenital disorders of glycosylation are a significant underlying cause of developmental and epileptic encephalopathy (DEE). A subset of these DEE cases results from biallelic variants in the unique, essential gene encoding UDP-glucose dehydrogenase (UGDH). The UGDH enzyme catalyzes two successive NAD+- dependent oxidation reactions to convert the C6 hydroxyl of UDP-glucose to a carboxylate, generating the UDP-glucuronate product.

View Article and Find Full Text PDF

Introduction: Jamuar syndrome, caused by a mutation in a protein-coding gene called the UGDH (UDP-glucose 6-dehydrogenase), is an extremely rare genetic condition that presents with craniofacial dysmorphisms, developmental delay and epileptic encephalopathy. Despite its rarity, a proper diagnosis and management depends on the knowledge of its oral clinical presentation and genetic foundation to ensure thorough oral rehabilitation.

Case Presentation: The clinical characteristics of Jamuar disease described in this report are of two siblings, 20- and 13-year-old sisters, who both displayed a constellation of symptoms consistent with the disease.

View Article and Find Full Text PDF

This study aimed to present a quantitative modeling and simulation approach for oral henagliflozin, a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor primarily metabolized by uridine diphosphate-glucuronosyltransferase (UGT) enzymes. A physiologically-based pharmacokinetic (PBPK) model for henagliflozin was developed using in vitro metabolism and clinical pharmacokinetic (PK) data, with validation across multiple contexts, including healthy adults, and hepatic impairment populations. Additionally, empirical pharmacodynamic (PD) modeling was employed to optimize pediatric dosing based on exposure-response relationships for urinary glucose excretion (UGE).

View Article and Find Full Text PDF